5 Pharmaceutical and biological preparations for clinical medical use, namely, for use in IGF-I deficiency, growth hormone insensitivity syndrome, growth disorders, severe burns, severe insulin resistance, Type 2 diabetes, Type 1 diabetes, muscular dystrophies, amyotrophic lateral sclerosis, retinopathy of prematurity, osteoporosis, and AIDS adipose redistribution syndrome; inoculations for use in the treatment of type I diabetes, type II diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), metabolic syndrome; (syndrome X); polycystic ovary disease, infertility, hirsutism, hyperandrogenemia, severe burns, growth hormone insufficiency syndrome (GHIS also known as Laron Dwarfism), myotonic dystrophy, AIDS lipodystrophy, inflammatory disease, endocrine disease, reproductive disease, cancer, bacterial infection, viral infection, parasite infection, autoimmune disease, central nervous system disorders and neural tube defects; neutraceuticals for the treatment of type II diabetes, impaired glucose tolerance (IGT), impaired fasting glucose (IFG), metabolic syndrome (Syndrome X), polycystic ovary disease, infertility, hirsutism, hyperandrogenemia and neural tube defects
Trademark: 85011369
